Obesity in India: New Drugs, Rising Rates & Why It’s Not a Quick Fix

The conversation around obesity is shifting. It’s no longer simply a matter of lifestyle choices, but a complex interplay of hormonal factors, genetics, psychological well-being, and even the environment we live in. In India, rising rates of severe obesity – a Body Mass Index (BMI) of 35 or higher – and what’s termed ‘metabolic obesity’ are becoming significant public health concerns, even among individuals with a seemingly normal BMI. These trends highlight the need for a more nuanced understanding of weight management, moving beyond simplistic solutions.

Newer medications like semaglutide and tirzepatide have generated considerable excitement due to their effectiveness in clinical trials, targeting appetite regulation in the brain, slowing gastric emptying, and improving metabolic health markers. Though, experts emphasize that these aren’t ‘quick fixes’ and that a truly effective approach to weight management requires addressing the underlying hormonal, psychological, and lifestyle factors contributing to the problem.

Understanding the Complexities of Obesity in India

Obesity in India is often linked to underlying conditions, particularly in women. As Dr. Subramanian Kannan, Director of Endocrinology and Diabetology at Narayana Health City (Bengaluru), explains, Polycystic Ovary Syndrome (PCOS) is a common cause of weight gain and obesity in young women due to hormonal imbalances. PCOS, affecting 6-10% of women, is characterized by hyperandrogenism, polycystic ovaries, and ovulatory dysfunction, and is frequently associated with metabolic issues like insulin resistance. Similarly, certain medications, such as steroids and some antidepressants, can also contribute to weight gain. A thorough medical history is crucial to identify these contributing factors.

Beyond these specific conditions, Dr. Kannan points to the impact of chronic stress, poor sleep, and what he describes as an “obesogenic environment” – one that promotes overconsumption of calories and discourages physical activity. These factors can disrupt the delicate balance of hormones like ghrelin (which stimulates appetite) and leptin (which signals fullness), leading to intense cravings for high-calorie foods. Research also highlights regional variations in obesity prevalence within India, suggesting the influence of socio-demographic factors and dietary habits.

How Newer Obesity Medications Operate

Semaglutide and tirzepatide represent a latest class of obesity medications that work by mimicking natural hormones called incretins, produced in the gut. These medications act on multiple physiological systems:

• Brain: They influence the brain’s hunger and satiety centers, reducing appetite and minimizing intrusive thoughts about food.
• Digestive Tract: They slow down gastric emptying, creating a prolonged feeling of fullness after meals.
• Pancreas: They stimulate insulin secretion and suppress glucagon release, helping to stabilize blood sugar levels.

Clinical trials have demonstrated significant effectiveness with these medications. Dr. Kannan notes that they can reduce liver fat by 30% to 50%, and improve blood pressure. Importantly, these drugs also offer cardiovascular protection, reducing the risk of major adverse cardiovascular events like heart attack and stroke, as evidenced by large-scale cardiovascular outcome trials (CVOTs).

Metabolic Obesity: A Hidden Risk

A concerning trend identified by Dr. Kannan is the rise of ‘metabolic obesity’ – a condition where individuals may have a normal BMI but still carry a significant amount of visceral fat (fat around the internal organs). This type of fat distribution is particularly dangerous due to the fact that it’s strongly linked to metabolic diseases like type 2 diabetes and heart disease. While global data suggests a potential decrease in severe obesity in some regions, India is experiencing an increase in individuals with BMIs over 35 or 40, alongside a growing number of cases of metabolic obesity, even in those with lower BMIs.

The Role of Thyroid Function

Thyroid disorders, particularly hypothyroidism (underactive thyroid), can also contribute to weight gain. The thyroid hormone regulates metabolism, and when levels are low, metabolism slows down, leading to weight gain even with a normal diet. Addressing thyroid imbalances is therefore an important component of a comprehensive weight management strategy.

Obesity in Children and Adolescents

Genetics play a role in obesity, with an 80% chance of children being obese if both parents are. However, genetics only provide a predisposition; lifestyle choices and environmental factors are the key triggers. The availability of inexpensive, high-calorie processed foods and increasingly sedentary lifestyles contribute to an ‘obesogenic environment’ that makes it easy to overconsume calories and difficult to burn them off.

Beyond Medication: A Holistic Approach

Dr. Kannan emphasizes that obesity injections are not a standalone solution. He stresses the importance of addressing the psychological impact of obesity, which is often associated with depression, low self-esteem, and social isolation. A holistic treatment approach should address both physical and mental health. Weight loss often begins within the first 2 to 4 weeks of starting obesity injections, but sustained success requires a commitment to lifestyle changes, including a healthy diet, regular physical activity, and stress management techniques.

What to Expect as Treatment Evolves

The understanding of obesity is constantly evolving, and treatment approaches are likely to become even more personalized and comprehensive. Ongoing research is focused on identifying new targets for pharmacological interventions, developing more effective behavioral therapies, and addressing the social and environmental factors that contribute to obesity. Regular reviews of clinical guidelines and surveillance data will be crucial to ensure that treatment strategies remain evidence-based and responsive to changing trends. The Indian PCOS Task Force is actively working to provide validated treatment approaches for managing PCOS associated with obesity in Indian women, reflecting a commitment to evidence-based clinical insights.